Malek E - Search Results

1

Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.

Abdel Malek MA, Jagannathan S, Malek E, Sayed DM, Elgammal SA, Abd El-Azeem HG, Thabet NM, Driscoll JJ. Abdel Malek MA, et al. Among authors: malek e. Oncotarget. 2015 Feb 20;6(5):3098-110. doi: 10.18632/oncotarget.3075. Oncotarget. 2015. PMID: 25605012 Free PMC article.

2

MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.

Alsidawi S, Malek E, Driscoll JJ. Alsidawi S, et al. Among authors: malek e. Int J Mol Sci. 2014 Jun 11;15(6):10508-26. doi: 10.3390/ijms150610508. Int J Mol Sci. 2014. PMID: 24921708 Free PMC article. Review.

3

Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.

Malek E, Jagannathan S, Driscoll JJ. Malek E, et al. Oncotarget. 2014 Sep 30;5(18):8027-38. doi: 10.18632/oncotarget.2469. Oncotarget. 2014. PMID: 25275300 Free PMC article. Review.

4

Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells.

Jaganathan S, Malek E, Vallabhapurapu S, Vallabhapurapu S, Driscoll JJ. Jaganathan S, et al. Among authors: malek e. Oncotarget. 2014 Dec 15;5(23):12358-70. doi: 10.18632/oncotarget.2590. Oncotarget. 2014. PMID: 25481044 Free PMC article.

5

Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib.

Jagannathan S, Abdel-Malek MA, Malek E, Vad N, Latif T, Anderson KC, Driscoll JJ. Jagannathan S, et al. Among authors: malek e. Leukemia. 2015 Nov;29(11):2184-91. doi: 10.1038/leu.2015.157. Epub 2015 Jun 25. Leukemia. 2015. PMID: 26108695 Free PMC article.

6

Metabolic tumor volume on interim PET is a better predictor of outcome in diffuse large B-cell lymphoma than semiquantitative methods.

Malek E, Sendilnathan A, Yellu M, Petersen A, Fernandez-Ulloa M, Driscoll JJ. Malek E, et al. Blood Cancer J. 2015 Jul 24;5(7):e326. doi: 10.1038/bcj.2015.51. Blood Cancer J. 2015. PMID: 26207787 Free PMC article. No abstract available.

7

Myeloid-derived suppressor cells: The green light for myeloma immune escape.

Malek E, de Lima M, Letterio JJ, Kim BG, Finke JH, Driscoll JJ, Giralt SA. Malek E, et al. Blood Rev. 2016 Sep;30(5):341-8. doi: 10.1016/j.blre.2016.04.002. Epub 2016 Apr 12. Blood Rev. 2016. PMID: 27132116 Free PMC article. Review.

8

High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib.

Malek E, Driscoll JJ. Malek E, et al. Oncotarget. 2016 Jun 21;7(25):38523-38538. doi: 10.18632/oncotarget.9568. Oncotarget. 2016. PMID: 27229530 Free PMC article.

9

Pharmacogenomics and chemical library screens reveal a novel SCF^SKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma.

Malek E, Abdel-Malek MA, Jagannathan S, Vad N, Karns R, Jegga AG, Broyl A, van Duin M, Sonneveld P, Cottini F, Anderson KC, Driscoll JJ. Malek E, et al. Leukemia. 2017 Mar;31(3):645-653. doi: 10.1038/leu.2016.258. Epub 2016 Sep 28. Leukemia. 2017. PMID: 27677741 Free PMC article.

10

Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.

Malek E, Kim BG, Driscoll JJ. Malek E, et al. Genes (Basel). 2016 Oct 6;7(10):84. doi: 10.3390/genes7100084. Genes (Basel). 2016. PMID: 27782060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters